Literature DB >> 19738137

Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized controlled trial.

Michelli C de Assis1, Eneida R Rabelo, Christiane W Avila, Carisi Anne Polanczyk, Luis E Rohde.   

Abstract

BACKGROUND: Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical applicability of this interaction has not been evaluated adequately in prospective studies. METHODS AND
RESULTS: In a randomized controlled trial that enrolled outpatients with a recent international normalized ratio (INR) outside the therapeutic target, we compared 2 strategies to optimize long-term oral anticoagulation: (1) a conventional approach based on changes in anticoagulant prescription and (2) a dietary vitamin K-guided strategy based on simple modifications of the amount of vitamin K-rich foods ingested per week. The primary efficacy end point was the percentage of patients who achieved a prespecified INR target at 90 days after randomization. Study population (n=132) predominantly included men with mechanical heart prostheses (58%) or atrial fibrillation (35%). Over time, patients allocated to the vitamin K-guided strategy reached the prespecified INR more frequently so that after 90 days of follow-up, 74% were on target compared with 58% of patients managed conventionally (P=0.04). Patients allocated to the dietary vitamin K-guided strategy had the same magnitude and direction of INR variation as those observed with the conventional approach in the short term (15 days) for both underanticaogulated and overanticoagulated patients. Minor bleeding or use of parenteral vitamin K were also marginally less frequent in patients managed according to the dietary intervention (1 [1.5%] versus 7 [11%]; P=0.06).
CONCLUSIONS: A vitamin K-guided management strategy to adjust long-term oral anticoagulation is feasible and safe and may result in an increased chance of reaching target levels of INR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19738137     DOI: 10.1161/CIRCULATIONAHA.109.849208

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.

Authors:  Andrea Lee; Mark Crowther
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

2.  Dietetic issues in antiphospholipid syndrome.

Authors:  Karin Klack; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

Review 3.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 4.  Warfarin and vitamin K intake in the era of pharmacogenetics.

Authors:  Yael Lurie; Ronen Loebstein; Daniel Kurnik; Shlomo Almog; Hillel Halkin
Journal:  Br J Clin Pharmacol       Date:  2010-08       Impact factor: 4.335

5.  Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario.

Authors:  Devendra Saksena; Yugal K Mishra; S Muralidharan; Vivek Kanhere; Pankaj Srivastava; C P Srivastava
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-01-28

6.  Novel anticoagulants in atrial fibrillation stroke prevention.

Authors:  Nicholas B Norgard; James J Dinicolantonio; Taylor J Topping; Benjamin Wee
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

7.  Influence of VKORC1 gene polymorphisms on the effect of oral vitamin K supplementation in over-anticoagulated patients.

Authors:  Priccila Zuchinali; Gabriela C Souza; Graziella Aliti; Mariana R Botton; Lívia Goldraich; Katia G Santos; Mara H Hutz; Eliane Bandinelli; Luis E Rohde
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

8.  Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake.

Authors:  Ryuhei Saito; Kenji Takeda; Kayo Yamamoto; Akihiko Nakagawa; Hirofumi Aoki; Kosuke Fujibayashi; Minoru Wakasa; Atsushi Motoyama; Mizuho Iwadare; Ryoko Ishida; Nakaba Fujioka; Taketsugu Tsuchiya; Hironobu Akao; Yasuyuki Kawai; Michihiko Kitayama; Kouji Kajinami
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

9.  Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy.

Authors:  Ji Na Park; Ji Sun Lee; Min Young Noh; Mi-Kyung Sung
Journal:  Clin Nutr Res       Date:  2015-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.